article thumbnail

GSK suffers another R&D setback, axing ulcerative colitis drug trial

pharmaphorum

GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week. The post GSK suffers another R&D setback, axing ulcerative colitis drug trial appeared first on.

article thumbnail

What are the top disease areas for clinical drug trials?

Drug Discovery World

AstraZeneca’s Evusheld became the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in the UK. The post What are the top disease areas for clinical drug trials? appeared first on Drug Discovery World (DDW).

article thumbnail

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

XTalks

It is the world’s first and only licensed malaria vaccine and also the first licensed for use against a human parasitic disease of any kind. Children have been the focus of malaria vaccine and drug trials because over 90 percent of deaths attributable to malaria are in African children under the age of five.